• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ANGIOJET; CATHETER, CORONARY, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ANGIOJET; CATHETER, CORONARY, ATHERECTOMY Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Vasoconstriction (2126); Hematuria (2558); Vascular Dissection (3160); Embolism/Embolus (4438)
Event Date 12/04/2021
Event Type  Injury  
Manufacturer Narrative
Date of event estimated using date journal article was published.Initial reporter facility name: department of interventional and vascular radiology, nanjing first hospital, nanjing medical university.Gong, m., he, x., zhao, b.Et al.Endovascular revascularization strategies using catheter-based thrombectomy versus conventional catheter-directed thrombolysis for acute limb ischemia.Thrombosis j 19, 96 (2021).Https://doi.Org/10.1186/s12959-021-00349-9.
 
Event Description
It was reported via journal article that patient complications occurred.The aim of this study was to compare the safety and effectiveness of thrombectomy approaches via either catheter-based thrombectomy (cbt) or catheter-directed thrombolysis (cdt).A total of 98 patients (mean age 69.7 years, 60 male) who underwent endovascular intervention for alifrom january 2015 to july 2019 were included.Of these, 57 were treated with primary cbt via a large-bore catheter, an angiojet catheter or rotarex catheter, and/or underwent low-dose cdt, and 41 were treated with primary cdt.The safety and effectiveness of cbt compared to conventional cdt and other various endovascular techniques were evaluated.The 30-day complications were recorded.In angiojet cases, there were 3 instances of procedure-related distal embolization, 1 major complication, and 1 minor complication.Patients who underwent primary cbt had slightly fewer complications than those who underwent primary cdt (p =.059), especially for minor complications (p =.036).Minor complications for the cbt group included vessel spasm (n = 3), dissection of the superficial femoral artery (n = 1), hematuria (n = 1) and hematoma of the puncture site (n = 1); the rate of complications was significantly lower than that for cdt.The major complication except for distal embolization of the cbt group was compartment syndrome (n=3) requiring surgery for calf fasciotomy.Cbt had a higher procedure-related distal embolization rate than those who underwent primary cdt (p =.009), in the subgroup analysis, rotarex catheters had more procedure-related distal emboli than large-bore catheters and angiojet catheters, yet the difference was not statistically significant among the 3 groups (p =.765).Owing to the small size of these vessels and underlying chronic disease, adjunctive cdts were performed, the dislodged thrombus was well treated without permanent sequelae.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ANGIOJET
Type of Device
CATHETER, CORONARY, ATHERECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key14654244
MDR Text Key293832687
Report Number2134265-2022-06635
Device Sequence Number1
Product Code MCX
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 06/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/27/2022
Initial Date FDA Received06/10/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
-
-